<DOC>
	<DOCNO>NCT02002455</DOCNO>
	<brief_summary>Prostate cancer ( PCa ) currently common neoplastic disease among men well-developed country 350 000 new case diagnose annually Europe 4 800 Finland . Due widespread use serum prostate specific antigen ( PSA ) asymptomatic men , patient present initially localized disease . Radical prostatectomy , radiotherapy ( RT ) active surveillance common management option patient localized PCa . Proper preoperative staging patient adverse feature biopsy candidate radical prostatectomy urgently need . For elderly men external beam RT prefer modality safely perform utilizing modern technique intensity modulate image guide radiotherapy ( IMRT IGRT ) . Since randomized study suggest dose response effect beyond 78-80 Gy newer technique aim dose escalation provide toxicity control . Therefore , ultra high dose IMRT/IGRT require visualization intracapsular disease receive high dose . Taken together , use accurate anatomical functional imaging modality essential plan nerve spar radical prostatectomy ultra high dose IMRT/IGRT Fluorine-18 label L-leucine analogue 1-amino-3-fluorocyclobutane-1-carboxylic acid ( FACBC ) show preferentially accumulate PCa nodal metastasis . By assist localization intraprostatic pelvic disease FACBC hybrid positron emission tomography/computed tomography ( PET/CT ) magnetic resonance imaging ( PET/MRI ) potential improve selection patient robot-assisted radical prostatectomy IMRT/IGRT . Anatomical MRI 1.5 Tesla ( T ) compare transrectal ultrasound demonstrate high sensitivity tumor detection almost specificity , stress need additional metabolic MRI . Advanced application MRI proton magnetic resonance spectroscopy ( 1H MRS ) , diffusion weight imaging ( DWI ) dynamic contrast enhance image ( DCE-MRI ) increasingly use detection characterization PCa . The use 3T scanner multiparametric MRI ( mpMRI ) , consist anatomical MRI , DWI , 1H MRS DCE-MRI , demonstrate promising result stag detection PCa .</brief_summary>
	<brief_title>Preoperative Staging Dose Escalated Radiotherapy Prostate Carcinoma With PET MRI</brief_title>
	<detailed_description>Specific aim current study follow : ) To determine sensitivity , specificity accuracy multiparametric 3T MRI , ( anatomical MRI , DCE-MRI , DWI 1H MRS ) combine FACBC PET/CT PET/MRI correlation systematic biopsy whole mount prostatectomy specimen . ii ) To asses applicability multiparametric 3T MRI combine FACBC-PET/CT PET/MRI detection cancer aggressiveness base Gleason score PSA . iii ) To develop quantitative qualitative method evaluation FACBC PET/MRI iv ) To develop validate imaging protocol become standard protocol prostate image surgical radiotherapy patient Turku PET Centre use hybrid PET/MRI</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<criteria>Age : 50 85 year old Language spoken : Finnish Swedish Diagnosis : Histologically confirm adenocarcinoma prostate Adequate histological sample consist least 3 biopsy sample lobe No previous surgical , radiation endocrine treatment prostate carcinoma Clinical stage T1cT3aN0 base transrectal ultrasound Serum creatinine â‰¤ 1,5 x upper limit normal ( ULN ) Patient agree undergo either surgery external radiotherapy Mental status : Patients must able understand meaning study Informed consent : The patient must sign appropriate Ethical Committee ( EC ) approve informed consent document presence designate staff Prior medical history : Patient must history serious cardiovascular , liver kidney disease Infections : Patient must uncontrolled serious infection No contraindication MRI ( cardiac pacemaker , intracranial clip etc ) Patient preference active surveillance method prostate cancer management</criteria>
	<gender>Male</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>FACBC</keyword>
	<keyword>PET/CT</keyword>
	<keyword>PET/MRI</keyword>
	<keyword>Radical prostatectomy</keyword>
	<keyword>Radiotherapy</keyword>
</DOC>